I think that those who are withdrawing support of the company may be sorry in the not so distant future. The magnitude of what LCT's development will have on diabetes is huge. The ability to encapsulate living cells without any need for anti rejection drugs is not only the solution for curing diabetes but also in possible treatments for other diseases which need huge amounts of immunosuppressants to make them viable.
They have just received the Australian patent for Immupel........
An excerpt taken from their website ....
IMMUPEL is a novel, proprietary encapsulation technology for encapsulating living cells prior to transplantation applications.? This selectively permeable system protects encapsulated living cells from immune rejection without the need for immunnosuppressant drugs, while at the same time allowing the transplanted cells to survive and function normally.
I for one have no intention of withdrawing support, and look forward to the huge monetary gains and medical advancements to follow.
LCT Price at posting:
10.5¢ Sentiment: Buy Disclosure: Held
